Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

BACKGROUND: Androgen-deprivation therapy (ADT) has been the backbone of treatment for metastatic prostate cancer since the 1940s. We assessed whether concomitant treatment with ADT plus docetaxel would result in longer overall survival than that with ADT alone. METHODS: We assigned men with metastat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:N Engl J Med
Autori principali: Sweeney, Christopher J., Chen, Yu-Hui, Carducci, Michael, Liu, Glenn, Jarrard, David F., Eisenberger, Mario, Wong, Yu-Ning, Hahn, Noah, Kohli, Manish, Cooney, Matthew M., Dreicer, Robert, Vogelzang, Nicholas J., Picus, Joel, Shevrin, Daniel, Hussain, Maha, Garcia, Jorge A., DiPaola, Robert S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4562797/
https://ncbi.nlm.nih.gov/pubmed/26244877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1503747
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi